ReproUnion
  • About
    • About Infertility
    • About ReproUnion
    • The Partners
    • Executive Board
    • Management Unit
    • PhD/postdoc project (2015-18)
    • Challenge concept (2019-22)
    • Publications
    • About ReproYoung
  • Innovation Platform
    • What is the Innovation Platform?
    • Collaboration
    • Innovation projects
    • Guidance: Inventions
  • Science
    • About Science
    • RUBIC Biobank
  • News
    • Latest News
      • 2025 News Archive
      • 2024 News Archive
      • 2023 News Archive
      • 2022 News Archive
      • 2021 News Archive
      • 2020 News Archive
      • 2019 News Archive
      • 2018 News Archive
      • 2017 News Archive
      • 2016 News Archive
      • 2015 News Archive
    • Spotlight Interviews
    • Media
      • 2025 Media Archive
      • 2024 Media Archive
      • 2023 Media Archive
      • 2022 Media archive
      • 2021 Media archive
      • 2020 Media archive
  • Events
    • Current Events
    • Previous Events
Select Page
HER2: Reducing the Impact of Ovarian sTimulation – RIOT B

HER2: Reducing the Impact of Ovarian sTimulation – RIOT B

by SimonLinden | Apr 30, 2021 | ReproUnion 1.0 Project

RIOT-B study is an extensive explorative part of the randomized placebo-controlled study RIOT-A. 33 out of the 130 patients enrolled in the RIOT-A study have undergone a course of intensive monitoring in first a natural cycle, then a subsequent RIOT-A treatment cy cle...
HER1: Reducing the Impact of Ovarian sTimulation – RIOT A

HER1: Reducing the Impact of Ovarian sTimulation – RIOT A

by SimonLinden | Apr 30, 2021 | ReproUnion 1.0 Project

In recent years, it has become evident that a number of challenges remain to be overcome to improve IVF outcome. One of these relates to implantation. Hormonal stimulation in connection to IVF treatment produces several mature follicles in the ovaries. This results in...
M3: Stratified treatment in ovarian hyper stimulation

M3: Stratified treatment in ovarian hyper stimulation

by SimonLinden | Apr 30, 2021 | ReproUnion 1.0 Project

 Background Women undergoing in vitro fertilization receive high doses of the gonadotropin follicle stimulating hormone (FSH), sometimes in combination with the gonadotropin luteinizing hormone (LH), for stimulation of the ovaries to obtain a high number of eggs....
RH GR2: Semen quality: A marker of health

RH GR2: Semen quality: A marker of health

by SimonLinden | Apr 30, 2021 | ReproUnion 1.0 Project

This study is performed by Lærke Priskorn at Department of Growth and Reproduction, Rigshospitalet, Denmark, in collaboration with Lund University, Sweden. Background and results Semen samples from 18-20-year-old men from the general population have since 1996 been...
From cutting edge science to treatment debate at Best of ASRM & ESHRE 2021

From cutting edge science to treatment debate at Best of ASRM & ESHRE 2021

by SimonLinden | Apr 28, 2021 | News

On the 8th of April 2021, Professor Eva Hoffmann was among the first presenters at the virtual ’Best of ASRM & ESHRE 2021’ conference with her lecture on Molecular mechanisms behind women’s biological clock. The lecture was in the cutting-edge track, illustrating...
« Older Entries
Next Entries »
Our partners


Contact us



Linkedin



Youtube